Drug Trial Radar · NCT01991795
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
Last checked: Nov 20, 2026Latest source record: Mar 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
19,271
Actual
Start
Feb 10, 2014
Primary completion
Jan 25, 2019
Study completion Jan 25, 2019
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Nov 25, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 50 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effect of ticagrelor versus placebo in patients with Type 2 Diabetes Mellitus.
Conditions
- Diabetes Mellitus, Type 2
Interventions
Ticagrelor 60 mgDrug
Ticagrelor 60 mg bd taken orally as tablets
Ticagrelor placeboDrug
Ticagrelor placebo bd taken orally as tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of Cardiovascular (CV) Death, MI or StrokeTime frame: From randomisation to primary analysis censoring date (PACD). Median time in study until PACD was 40 months.
Locations
1,237 sites in 43 countries. Site status is shown where the registry gives one.
Research Site
Alexander City, Alabama
Research Site
Birmingham, Alabama
Research Site
Fairhope, Alabama
Research Site
Huntsville, Alabama
Research Site
Huntsville, Alabama
Research Site
Mobile, Alabama
Research Site
Montgomery, Alabama
Research Site
Sheffield, Alabama
Research Site
Tuscumbia, Alabama
Research Site
Cottonwood, Arizona
Research Site
Glendale, Arizona
Research Site
Tucson, Arizona
Research Site
Little Rock, Arkansas
Research Site
Little Rock, Arkansas
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Bakersfield, California
Research Site
Beverly Hills, California
Research Site
Fremont, California
Research Site
Fresno, California
Research Site
Irvine, California
Research Site
La Mesa, California
Research Site
Long Beach, California
Research Site
Long Beach, California
Research Site
Los Alamitos, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Mission Hills, California
Research Site
Newport Beach, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
Stanford, California
Research Site
Stockton, California
Research Site
Tarzana, California
Research Site
Torrance, California
Research Site
Denver, Colorado
Research Site
Bridgeport, Connecticut
Research Site
Greenwich, Connecticut
Showing 40 of 1,237 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.